Evidence map›Paper›PMID 20002100›Full record

ArticleBritish journal of pharmacology2010

Arachidonic acid release mediated by OX1 orexin receptors.

Pauli M Turunen, Marie E Ekholm, Pentti Somerharju, Jyrki P Kukkonen

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. A molecular network map of orexin-orexin receptor signaling system.Journal of cell communication and signaling · 2023
    Article
  3. Orexin receptors in GtoPdb v.2021.3.IUPHAR/BPS guide to pharmacology CITE · 2021
    Article
  4. Article
  5. Review
  6. Orexin/hypocretin receptor signalling cascades.British journal of pharmacology · 2014
    Review
  7. Article
  8. Article
  9. Article
  10. Orexin/Hypocretin Signaling.Current topics in behavioral neurosciences
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pauli M TurunenDepartment of Basic Veterinary Sciences, Biochemistry, University of Helsinki, Helsinki, Finland.
Marie E Ekholm
Pentti Somerharju
Jyrki P Kukkonen
University of Helsinki · FIUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeWe have previously shown that lipid mediators, produced by phospholipase D and C, are generated in OX(1) orexin receptor signalling with high potency, and presumably mediate some of the physiological responses to orexin. In this study, we investigated whether the ubiquitous phospholipase A(2) (PLA(2)) signalling system is also involved in orexin receptor signalling. EXPERIMENTAL APPROACH: Recombinant Chinese hamster ovary-K1 cells, expressing human OX(1) receptors, were used as a model system. Arachidonic acid (AA) release was measured from (3)H-AA-labelled cells. Ca(2+) signalling was assessed using single-cell imaging. KEY

resultsOrexins strongly stimulated [(3)H]-AA release (maximally 4.4-fold). Orexin-A was somewhat more potent than orexin-B (pEC(50) = 8.90 and 8.38 respectively). The concentration-response curves appeared biphasic. The release was fully inhibited by the potent cPLA(2) and iPLA(2) inhibitor, methyl arachidonyl fluorophosphonate, whereas the iPLA(2) inhibitors, R- and S-bromoenol lactone, caused only a partial inhibition. The response was also fully dependent on Ca(2+) influx, and the inhibitor studies suggested involvement of the receptor-operated influx pathway. The receptor-operated pathway, on the other hand, was partially dependent on PLA(2) activity. The extracellular signal-regulated kinase, but not protein kinase C, were involved in the PLA(2) activation at low orexin concentrations. CONCLUSIONS AND IMPLICATIONS: Activation of OX(1) orexin receptors induced a strong, high-potency AA release, possibly via multiple PLA(2) species, and this response may be important for the receptor-operated Ca(2+) influx. The response coincided with other high-potency lipid messenger responses, and may interact with these signals.

Indexed as

AnimalsArachidonic AcidCalcium SignalingCHO CellsCricetinaeCricetulusDose-Response Relationship, DrugExtracellular Signal-Regulated MAP KinasesHumansIntracellular Signaling Peptides and ProteinsNeuropeptidesOrexin ReceptorsOrexinsPhospholipases A2Receptors, G-Protein-CoupledReceptors, NeuropeptideArachidonic AcidExtracellular Signal-Regulated MAP KinasesHCRT protein, humanIntracellular Signaling Peptides and ProteinsNeuropeptidesOrexin ReceptorsOrexinsPhospholipases A2Receptors, G-Protein-CoupledReceptors, Neuropeptide

Identifiers

PMID20002100
PMCPMC2823366
OpenAlexW1501722970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.